vs

Side-by-side financial comparison of CABOT CORP (CBT) and Paychex (PAYX). Click either name above to swap in a different company.

Paychex is the larger business by last-quarter revenue ($1.5B vs $849.0M, roughly 1.8× CABOT CORP). Paychex runs the higher net margin — 26.3% vs 8.6%, a 17.7% gap on every dollar of revenue. On growth, Paychex posted the faster year-over-year revenue change (17.4% vs -11.1%). Paychex produced more free cash flow last quarter ($382.8M vs $57.0M). Over the past eight quarters, Paychex's revenue compounded faster (3.8% CAGR vs -8.7%).

Cabot Corporation is an American specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company operates in over 20 countries with 36 manufacturing plants, eight research and development facilities, and 28 sales offices.

Paychex, Inc. is an American company that provides human resources, payroll, and employee benefits outsourcing services for small- to medium-sized businesses. Founded in 1971 and headquartered in Rochester, New York, the company has more than 100 offices serving approximately 800,000 payroll clients in the U.S. and Europe. Paychex is ranked 681st on the Fortune 500 list of largest corporations by revenue.

CBT vs PAYX — Head-to-Head

Bigger by revenue
PAYX
PAYX
1.8× larger
PAYX
$1.5B
$849.0M
CBT
Growing faster (revenue YoY)
PAYX
PAYX
+28.5% gap
PAYX
17.4%
-11.1%
CBT
Higher net margin
PAYX
PAYX
17.7% more per $
PAYX
26.3%
8.6%
CBT
More free cash flow
PAYX
PAYX
$325.8M more FCF
PAYX
$382.8M
$57.0M
CBT
Faster 2-yr revenue CAGR
PAYX
PAYX
Annualised
PAYX
3.8%
-8.7%
CBT

Income Statement — Q1 FY2026 vs Q2 FY2026

Metric
CBT
CBT
PAYX
PAYX
Revenue
$849.0M
$1.5B
Net Profit
$73.0M
$395.4M
Gross Margin
24.9%
72.6%
Operating Margin
15.2%
38.0%
Net Margin
8.6%
26.3%
Revenue YoY
-11.1%
17.4%
Net Profit YoY
-21.5%
-4.4%
EPS (diluted)
$1.37
$1.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBT
CBT
PAYX
PAYX
Q4 25
$849.0M
$1.5B
Q3 25
$899.0M
$1.5B
Q2 25
$923.0M
$1.4B
Q1 25
$936.0M
$1.5B
Q4 24
$955.0M
$1.3B
Q3 24
$1.0B
$1.3B
Q2 24
$1.0B
$1.3B
Q1 24
$1.0B
$1.4B
Net Profit
CBT
CBT
PAYX
PAYX
Q4 25
$73.0M
$395.4M
Q3 25
$43.0M
$383.8M
Q2 25
$101.0M
$297.2M
Q1 25
$94.0M
$519.3M
Q4 24
$93.0M
$413.4M
Q3 24
$137.0M
$427.4M
Q2 24
$109.0M
$379.9M
Q1 24
$84.0M
$498.6M
Gross Margin
CBT
CBT
PAYX
PAYX
Q4 25
24.9%
72.6%
Q3 25
24.5%
72.3%
Q2 25
26.4%
71.5%
Q1 25
25.7%
73.6%
Q4 24
24.6%
70.4%
Q3 24
24.0%
70.3%
Q2 24
25.2%
70.1%
Q1 24
24.1%
72.8%
Operating Margin
CBT
CBT
PAYX
PAYX
Q4 25
15.2%
38.0%
Q3 25
15.2%
36.3%
Q2 25
18.1%
31.2%
Q1 25
17.3%
47.2%
Q4 24
16.2%
42.0%
Q3 24
15.0%
42.7%
Q2 24
16.9%
38.3%
Q1 24
15.3%
46.6%
Net Margin
CBT
CBT
PAYX
PAYX
Q4 25
8.6%
26.3%
Q3 25
4.8%
25.7%
Q2 25
10.9%
21.5%
Q1 25
10.0%
35.4%
Q4 24
9.7%
32.3%
Q3 24
13.7%
33.4%
Q2 24
10.7%
30.2%
Q1 24
8.2%
35.7%
EPS (diluted)
CBT
CBT
PAYX
PAYX
Q4 25
$1.37
$1.10
Q3 25
$0.80
$1.06
Q2 25
$1.86
$0.83
Q1 25
$1.69
$1.43
Q4 24
$1.67
$1.14
Q3 24
$2.41
$1.18
Q2 24
$1.94
$1.05
Q1 24
$1.49
$1.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBT
CBT
PAYX
PAYX
Cash + ST InvestmentsLiquidity on hand
$230.0M
$1.5B
Total DebtLower is stronger
$5.0B
Stockholders' EquityBook value
$1.6B
$3.9B
Total Assets
$3.8B
$16.5B
Debt / EquityLower = less leverage
1.28×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBT
CBT
PAYX
PAYX
Q4 25
$230.0M
$1.5B
Q3 25
$258.0M
$1.7B
Q2 25
$239.0M
$1.7B
Q1 25
$213.0M
$1.6B
Q4 24
$183.0M
$1.2B
Q3 24
$223.0M
$1.5B
Q2 24
$197.0M
$1.5B
Q1 24
$206.0M
$1.7B
Total Debt
CBT
CBT
PAYX
PAYX
Q4 25
$5.0B
Q3 25
$1.1B
$5.0B
Q2 25
$4.9B
Q1 25
Q4 24
Q3 24
$1.1B
Q2 24
$798.6M
Q1 24
Stockholders' Equity
CBT
CBT
PAYX
PAYX
Q4 25
$1.6B
$3.9B
Q3 25
$1.6B
$4.0B
Q2 25
$1.5B
$4.1B
Q1 25
$1.4B
$4.1B
Q4 24
$1.4B
$3.9B
Q3 24
$1.4B
$3.9B
Q2 24
$1.3B
$3.8B
Q1 24
$1.4B
$3.7B
Total Assets
CBT
CBT
PAYX
PAYX
Q4 25
$3.8B
$16.5B
Q3 25
$3.8B
$16.7B
Q2 25
$3.8B
$16.6B
Q1 25
$3.8B
$11.2B
Q4 24
$3.6B
$10.6B
Q3 24
$3.7B
$10.5B
Q2 24
$3.6B
$10.4B
Q1 24
$3.6B
$13.0B
Debt / Equity
CBT
CBT
PAYX
PAYX
Q4 25
1.28×
Q3 25
0.70×
1.25×
Q2 25
1.20×
Q1 25
Q4 24
Q3 24
0.75×
Q2 24
0.21×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBT
CBT
PAYX
PAYX
Operating Cash FlowLast quarter
$126.0M
$444.9M
Free Cash FlowOCF − Capex
$57.0M
$382.8M
FCF MarginFCF / Revenue
6.7%
25.5%
Capex IntensityCapex / Revenue
8.1%
4.1%
Cash ConversionOCF / Net Profit
1.73×
1.13×
TTM Free Cash FlowTrailing 4 quarters
$401.0M
$2.0B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBT
CBT
PAYX
PAYX
Q4 25
$126.0M
$444.9M
Q3 25
$219.0M
$718.4M
Q2 25
$249.0M
$343.8M
Q1 25
$73.0M
$716.0M
Q4 24
$124.0M
$295.0M
Q3 24
$204.0M
$546.1M
Q2 24
$207.0M
$221.7M
Q1 24
$176.0M
$671.7M
Free Cash Flow
CBT
CBT
PAYX
PAYX
Q4 25
$57.0M
$382.8M
Q3 25
$155.0M
$662.5M
Q2 25
$188.0M
$283.3M
Q1 25
$1.0M
$667.3M
Q4 24
$47.0M
$248.0M
Q3 24
$112.0M
$510.5M
Q2 24
$155.0M
$180.4M
Q1 24
$133.0M
$631.0M
FCF Margin
CBT
CBT
PAYX
PAYX
Q4 25
6.7%
25.5%
Q3 25
17.2%
44.4%
Q2 25
20.4%
20.5%
Q1 25
0.1%
45.5%
Q4 24
4.9%
19.4%
Q3 24
11.2%
39.9%
Q2 24
15.3%
14.4%
Q1 24
13.1%
45.2%
Capex Intensity
CBT
CBT
PAYX
PAYX
Q4 25
8.1%
4.1%
Q3 25
7.1%
3.7%
Q2 25
6.6%
4.4%
Q1 25
7.7%
3.3%
Q4 24
8.1%
3.7%
Q3 24
9.2%
2.8%
Q2 24
5.1%
3.3%
Q1 24
4.2%
2.9%
Cash Conversion
CBT
CBT
PAYX
PAYX
Q4 25
1.73×
1.13×
Q3 25
5.09×
1.87×
Q2 25
2.47×
1.16×
Q1 25
0.78×
1.38×
Q4 24
1.33×
0.71×
Q3 24
1.49×
1.28×
Q2 24
1.90×
0.58×
Q1 24
2.10×
1.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBT
CBT

Reinforcement Materials$520.0M61%
Performance Chemicals$300.0M35%
Shipping And Handling$25.0M3%
Other Products And Services$4.0M0%

PAYX
PAYX

Management Solutions$1.2B78%
Peo And Insurance Solutions$336.9M22%

Related Comparisons